EIF5A2 and neoplasm: Despite significant inhibition of tumor angiogenesis by EIF5A2 ablation, obvious suppression of liver tumor growth was not observed in this study, indicating that agent targeting angiogenesis itself may not be able to sufficiently inhibit tumor growth.